NCT06607744 - Determine the Bioavailability of Selegiline TDS 6mg/24 Hours vs EMSAM in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

March 25, 2025

Study Completion Date

March 25, 2025

Conditions

MDD

Interventions

DRUG

Pharmacokinetic profiles of Selegiline TDS and EMSAM

Selegiline concentrations will be measured in blood plasma using a validated liquid chromatography tandem mass spectrometry method from Selegiline TDS (test formulation 6mg/24 hours) and EMSAM (6mg/24 hours). The analytical laboratory will be blinded as to samples which are the test and reference products.

Trial Locations (2)

68000

RECRUITING

Hospital Ampang, Pandan Mewah

94300

ACTIVE_NOT_RECRUITING

Sarawak General Hospital, Samoran

All Listed Sponsors

lead

Corium Innovations, Inc.

INDUSTRY